This information is intended for healthcare professionals only

JUVÉDERM® –Long Effectiveness, natural results & high patient satisfaction

HIGH QUALITY DESIGN AND MANUFACTURING IN EVERY SYRINGE¹ JUVÉDERM® delivers predictable outcomes and high patient satis- faction.2-3 NO OTHER HA DERMAL FILLER HAS LONGER DURATION THAN JUVÉDERM®* Results can, depending on chosen filler and area treated, last up to 9-24 months.4-5 TAILORED TREATMENT PLAN TO ACHIEVE AN INDIVIDUAL LOOK6-7 JUVÉDERM®s versatile portfolio is designed to meet varied patient and practice needs.⁸

*Based on a search of published clinical studies of HA facial fillers in November 2019 and an updated search in August 2022. A duration of 24 months was established in Juvéderm® VOLUMA with lidocaine, depending on the treatment area chosen References: 1. AbbVie. The highest standards of quality and safety. Available at: https://www.abbvie.com/societal-impact/for-the-well-being-of-our-patients/ upholding-the-highest-quality.html. [Accessed November 2022]. 2. Ogilvie P et al. Dermatol Surg. 2019;45(10):1294–1303. 3. Ogilvie P et al. J Cosmet Dermatol. 2020;19:1065–1070. 4. Pinsky MA et al. Aesthetic Surg J. 2008;28:17–23. 5. Callan P et al. Clin Cosmet Invest Dermatol. 2013; 681-89. 6. Liew S et al. J Cosmet Dermatol. 2020;19:296–302. 7. Gutowski KA. Clin Plast Surg. 2016;43:489–496. 8. Lanigan S. J Cosmet Dermatol. 2011;10:11–14.

Individualised result with VYCROSS®

References: 1. Liew S et al. J Cosmet Dermatol. 2020;19:296–302 2. Pinsky MA et al. Aesthetic Surg J. 2008;28:17–23. 3. Callan P et al. Clin Cosmet Invest Dermatol. 2013; 681-89. 4. Hee CK et al. Dermatol Surg. 2015;41(Suppl 1):S373–381. 5. Beer K et al. Dermatol Surg. 2021;47:80–85. 6. de la Guardia, C., Virno, A., Musumeci, M., Bernardin, A., & Silberberg, M. B. (2022). Facial plastic surgery : FPS, 10.1055/s-0041-1741560; https://doi.org/10.1055/s-0041-1741560

Embracing Individuality¹ for you and your patients

References: 1. Liew S et al. J Cosmet Dermatol. 2020;19:296–302 2. Baumann LS et al. Dermatol Surg. 2007;33:S128–35 3. Goodman GJ et al. Plast Reconstr Surg. 2015;136:139S–48S. 4. Pinsky MA et al. Aesthetic Surg J. 2008;28:17–23.5. Callan P et al. Clin Cosmet Invest Dermatol. 2013; 681-89. 6. de la Guardia, C., Virno, A., Musumeci, M., Bernardin, A., & Silberberg, M. B. (2022). Facial plastic surgery : FPS, 10.1055/s-0041-1741560; https://doi.org/10.1055/s-0041-1741560. 7. Juvéderm ULTRA DFU.

Enhanced Injection Experience with JUVEDERM®

Improved ease, comfort and muscle fatigue while injecting via JUVÉDERM®’s innovative ergonomic syringe1,2

Improved injection comfort1-2

Little effort required for serial injections1-2

Good visibility of the product lines through different colours1-2

Lighter aspiration that helps reduce the risk of vascular complications1-2

References: 1. Costello K et al. In-field assessment of the perception of smoothness when dispensing different filler formulations. International Master Course on Aging Science (IMCAS), 3–5 June 2022, Paris, France. https://abbvie1.outsystemsenterprise.com/GMAEventPublications/Assets. aspx?ConferenceId=299 2. Costello K et al. A new dermal filler syringe with improved ergonomic performance to enhance end-user experience. International Master Course on Aging Science (IMCAS), 3–5 June 2022, Paris, France. https://abbvie1.outsystemsenterprise.com/GMAEventPublications/Assets. aspx?ConferenceId=299.

Allergan Aesthetics A reliable partner A premium portfolio We are committed to supporting healthcare professionals with a premium selection of top aesthetic brands and innovative solutions. We combine cutting-edge products, education, and exceptional support to help you grow your practice and deliver outstanding results for your patients. We look forward to have you onboard as a new client, to be a part of your Aestetics journey and supporting you every step of the way!

If you would like to contact us, please mail all communications to: AbbVie AB | Box 1523, 171 29 Solna | +46 (0)8 684 44 600 | info@abbvie.se. Abbvie reserves the right to alter or cancel the program with no advance notice or obligation. © 2022 AbbVie. All rights reserved. All trademarks are the property of their respective owners. Approval number SE-AGNA-250001 | Date of preparation: January 2025.

Juvéderm® JUVÈDERM® Material provided by Allergan Aesthetics, an AbbVie company. AbbVie AB | Box 1523, 171 29 Solna | +46 (0)8 684 44 600 | info@abbvie.se. All rights reserved. All trademarks are the property of their respective owners. JUVÈDERM® is a medical device Class III CE0334. License details and indications may vary between countries - please consult individual product ”Directions for Use”. The most commonly reported side effects with JUVÉDERM® injectable gels included redness, swelling, pain, tenderness, firmness, lumps/bumps, bruising, discoloration, and itching. www.juvederm.se www.juvederm.dk www.juvederm.fi www.juvedermit.no